Faron Nicholas, Hoekel James, Tychsen Lawrence
John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University in St. Louis School of Medicine, St. Louis, Missouri; Department of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri; Department of Neuroscience, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
J AAPOS. 2021 Feb;25(1):27.e1-27.e8. doi: 10.1016/j.jaapos.2020.09.011. Epub 2021 Feb 20.
To analyze outcomes in a large cohort of spectacle-aversive children with high myopia who were treated by implantation of the Ophtec-Artisan or Visian phakic intraocular lens (pIOL).
Outcome data were collated retrospectively in 78 children (115 eyes) implanted with the Ophtec-Artisan iris-enclaved anterior chamber pIOL and 91 children (154 eyes) implanted with the Visian ICL (intraocular collamer lens) sulcus pIOL. All children had difficulties with spectacle or contact lens wear. Mean age at surgery was 9.9 years; mean follow-up was 3.9 years (range, 0.6-14.1 years).
A total of 248 of 269 eyes (92%) were corrected to within ± 0.5 D of their target value. Spherical correction averaged 12.3 ± 1.0 D. Refractive spherical regression was -0.04 D/year at last follow-up. Uncorrected distance visual acuity improved from an average logMAR 1.8 to 0.4; corrected distance visual acuity improved an average 0.3 logMAR. Of the treated children, 68% had a gain in binocular fusion. Neurobehavioral and/or visuomotor comorbidities were present in 87% of children. Five eyes (2%) developed retinal detachment an average 6 years after implantation. Nine eyes (3%) implanted with the Ophtec-Artisan pIOL required repositioning after trauma.
Implantation of pIOLs in children is an effective method for correcting high myopia in spectacle noncompliant children. Rates of myopic regression after pIOL surgery are substantially lower than those reported for children treated by excimer laser photorefractive keratectomy (PRK). The prevalence of major complications was relatively low in this high-risk population.
分析大量患有高度近视且厌恶佩戴眼镜的儿童,在植入Ophtec-Artisan或Visian有晶状体眼人工晶状体(pIOL)后的治疗效果。
对78名植入Ophtec-Artisan虹膜固定前房型pIOL的儿童(115只眼)和91名植入Visian ICL(可植入式胶原晶状体)睫状沟pIOL的儿童(154只眼)的治疗结果数据进行回顾性整理。所有儿童佩戴眼镜或隐形眼镜均有困难。手术时的平均年龄为9.9岁;平均随访时间为3.9年(范围0.6 - 14.1年)。
269只眼中共有248只眼(92%)的矫正视力达到目标值±0.5 D以内。平均球镜矫正度数为12.3 ± 1.0 D。在最后一次随访时,屈光性球镜度数每年回退-0.04 D。未矫正的远视力从平均logMAR 1.8提高到0.4;矫正后的远视力平均提高0.3 logMAR。在接受治疗的儿童中,68%的儿童双眼融合功能得到改善。87%的儿童存在神经行为和/或视觉运动合并症。5只眼(2%)在植入后平均6年发生视网膜脱离。9只植入Ophtec-Artisan pIOL的眼(3%)在受到外伤后需要重新定位。
对儿童植入pIOL是矫正不依从佩戴眼镜的儿童高度近视的有效方法。pIOL手术后近视回退率显著低于接受准分子激光屈光性角膜切削术(PRK)治疗的儿童。在这个高风险人群中,主要并发症的发生率相对较低。